We are live on !
Find out more
Roberts, Glore & Co Portfolio holdings
AUM
$416M
Turnover
9.34%
1-Year Est. Return
21.8%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+21.8%
3 Year Est. Return
+82.69%
5 Year Est. Return
+98.42%
10 Year Est. Return
+313.14%
AUM
$416M
AUM Growth
+$11.2M
(+2.8%)
Cap. Flow
+$3.72M
Cap. Flow % of AUM
Cap. Flow %
0.89%
Top 10 Holdings %
Top 10 Hldgs %
35.41%
Holding
257
New
11
Increased
126
Reduced
77
Closed
13
Avg Time Held
6.2
years
Top 10 Avg Time Held
5.6
years
Top 20 Avg Time Held
5.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$1.11M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$668K |
| 3 |
Abbott
ABT
|
+$650K |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$628K |
| 5 |
Sprott Physical Gold and Silver Trust
CEF
|
+$468K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
|
+$2.74M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$655K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$490K |
| 4 |
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
|
+$434K |
| 5 |
Snowflake
SNOW
|
+$365K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.52% |
| 2 | Technology | 20.9% |
| 3 | Healthcare | 14.28% |
| 4 | Financials | 10.98% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
CME Group
CME
$114B
| $1.82M | 0.44% |
6,944
-80
| -1% | -$21.1K |
2013 Q2
53 quarters
|
|
52
Entergy
ETR
$53.1B
| $1.81M | 0.44% |
18,220
| – | – |
2013 Q2
53 quarters
|
|
53
Visa
V
$794B
| $1.79M | 0.43% |
4,970
-51
| -1% | -$18.6K |
2021 Q4
19 quarters
|
|
54
Broadcom
AVGO
$1.66T
| $1.78M | 0.43% |
5,059
+133
| +3% | +$50.1K |
2023 Q4
11 quarters
|
|
55
Procter & Gamble
PG
$394B
| $1.78M | 0.43% |
12,222
+470
| +4% | +$68.9K |
2013 Q2
53 quarters
|
|
|
56
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.3B
| $1.77M | 0.43% |
2,696
+971
| +56% | +$668K |
2019 Q4
27 quarters
|
|
57
Mercado Libre
MELI
$75.6B
| $1.76M | 0.42% |
1,018
-4
| -0.4% | -$7.42K |
2022 Q1
18 quarters
|
|
58
iShares 0-5 Year TIPS Bond ETF
STIP
$16.8B
| $1.74M | 0.42% |
17,444
+1,250
| +8% | +$126K |
2024 Q2
9 quarters
|
|
59
Novartis
NVS
$303B
| $1.73M | 0.42% |
12,160
-338
| -3% | -$51.3K |
2013 Q2
53 quarters
|
|
60
Vertex Pharmaceuticals
VRTX
$137B
| $1.69M | 0.41% |
3,225
+28
| +0.9% | +$14.3K |
2021 Q3
20 quarters
|
|
61
Coca-Cola
KO
$427B
| $1.65M | 0.4% |
19,128
-205
| -1% | -$17.8K |
2013 Q2
53 quarters
|
|
62
Centene
CNC
$35.3B
| $1.58M | 0.38% |
25,384
-461
| -2% | -$30.1K |
2015 Q4
43 quarters
|
|
63
Bio-Techne
TECH
$11.4B
| $1.56M | 0.38% |
21,521
-20
| -0.1% | -$1.44K |
2020 Q3
24 quarters
|
|
64
General Dynamics
GD
$98.2B
| $1.5M | 0.36% |
4,527
+135
| +3% | +$50.1K |
2013 Q2
53 quarters
|
|
65
Gilead Sciences
GILD
$208B
| $1.49M | 0.36% |
10,015
+130
| +1% | +$18.2K |
2013 Q2
53 quarters
|
|
66
Becton Dickinson
BDX
$59.4B
| $1.45M | 0.35% |
8,124
-290
| -3% | -$50.4K |
2013 Q2
53 quarters
|
|
67
Oracle
ORCL
$391B
| $1.4M | 0.34% |
10,188
+111
| +1% | +$15.7K |
2013 Q2
53 quarters
|
|
|
68
SpaceX
SPCX
$1.89T
| $1.39M | 0.34% |
9,244
+8,000
| +643% | +$1.11M |
2026 Q2
1 quarter
|
|
69
Lockheed Martin
LMT
$138B
| $1.37M | 0.33% |
2,687
-143
| -5% | -$78.6K |
2013 Q2
53 quarters
|
|
70
JPMorgan Chase
JPM
$919B
| $1.26M | 0.3% |
3,822
+8
| +0.2% | +$2.8K |
2020 Q3
24 quarters
|
|
71
Invesco Taxable Municipal Bond ETF
BAB
$861M
| $1.24M | 0.3% |
49,165
+2,195
| +5% | +$57.7K |
2016 Q1
42 quarters
|
|
72
Vanguard Morningstar Value ETF
VTV
$197B
| $1.22M | 0.29% |
5,645
-575
| -9% | -$128K |
2019 Q4
27 quarters
|
|
73
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $1.21M | 0.29% |
14,527
+2,220
| +18% | +$187K |
2019 Q4
27 quarters
|
|
74
Vanguard Total International Stock ETF
VXUS
$161B
| $1.15M | 0.28% |
13,586
+445
| +3% | +$38.2K |
2019 Q4
27 quarters
|
|
75
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $1.14M | 0.28% |
19,270
+401
| +2% | +$23.9K |
2013 Q2
53 quarters
|
|
Similar funds
CIM
RA
TM
Roberts, Glore & Co's Q3 2026 Portfolio in Review
As of Q3 2026, Roberts, Glore & Co held 257 positions worth $416M, up 2.8% from $404M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Roberts, Glore & Co's Q3 2026 filing shows 11 new, 126 increased, 77 reduced and 13 closed positions. Its largest new stake was BWX Technologies: 2,610 shares worth $358K. The largest sale was U.S. Small Cap Value Portfolio ETF Class Shares, an estimated $2.74M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- Roberts, Glore & Co's largest Q3 2026 buy was BWX Technologies: 2,610 shares worth $358K.
- Roberts, Glore & Co added most to SpaceX in Q3 2026, an estimated $1.11M increase.
- Roberts, Glore & Co's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $490K.
- Roberts, Glore & Co fully exited U.S. Small Cap Value Portfolio ETF Class Shares in Q3 2026, selling an estimated $2.74M.
- Roberts, Glore & Co's ten largest holdings make up 35% of its $416M portfolio in Q3 2026.
- Roberts, Glore & Co opened 11 new positions and closed 13 in Q3 2026.
- Roberts, Glore & Co's portfolio value rose 2.8% quarter-over-quarter to $416M.
Based on Roberts, Glore & Co's 13F filing for Q3 2026, filed 13 Nov 2026.